BVA decisions by condition

Restrictive lung disease interstitial pulmonary fibrosis: BVA grant rates and what wins

From 2017 to 2026, the Board of Veterans' Appeals decided a restrictive lung disease interstitial pulmonary fibrosis issue in 851 decisions. It granted the restrictive lung disease interstitial pulmonary fibrosis issue in 16.7% of them, below the 19.4% grant rate for all conditions, denied it in 29.4%, and remanded it in 53.1%. Counting only decisions on the merits (granted or denied), 36.2% were granted.

Decisions

851

2017–2026

Granted

16.7%

All conditions: 19.4%

Granted on the merits

36.2%

Granted ÷ (granted + denied)

Remanded

53.1%

Denied: 29.4%

Restrictive lung disease interstitial pulmonary fibrosis outcomes by year

YearIssues decidedGrantedDeniedRemandedOther
2018
50
8.0%32.0%60.0%0.0%
2019
81
11.1%30.9%56.8%1.2%
2020
99
14.1%29.3%56.6%0.0%
2021
81
13.6%27.2%59.3%0.0%
2022
99
17.2%18.2%63.6%1.0%
2023
93
15.1%31.2%50.5%3.2%
2024
103
21.4%30.1%47.6%1.0%
2025
181
18.8%31.5%49.2%0.6%
2026
55
29.1%34.5%36.4%0.0%

Each row counts issues (each condition the Board decided), so the shares add up to 100%. Other: dismissed, withdrawn or no clear outcome. Years with fewer than 50 issues are left out.

Evidence in granted and denied restrictive lung disease interstitial pulmonary fibrosis decisions

For each kind of supporting evidence: how often the Board granted the restrictive lung disease interstitial pulmonary fibrosis issue on the merits when the decision mentioned it, compared with decisions that did not. These are associations, not causes, and evidence is recorded per decision, not per issue.

In the recordDecisionsGranted when presentWhen absentDifference
Positive nexus opinion17567.2%21.7%+45.5 pts
Favorable VA exam8770.8%29.4%+41.4 pts
Treating physician opinion6163.2%33.3%+29.8 pts
Private medical opinion34248.9%24.8%+24.2 pts
Claimed as secondary15954.0%32.8%+21.1 pts
Combat service6550.0%34.8%+15.2 pts
Lay statement63632.7%49.4%−16.7 pts
  • The Board applied the benefit-of-the-doubt rule (38 CFR 3.102) in 70.4% of the decisions that granted restrictive lung disease interstitial pulmonary fibrosis.
  • The Board found the veteran's statements credible in 29.6% of grants and 11.2% of denials.

Negative evidence in the record

An unfavorable exam or a negative nexus opinion often sits in the same record as favorable evidence, and the Board weighs them against each other. So these rows show how often restrictive lung disease interstitial pulmonary fibrosis was still granted when the record contained the negative item, not that the item helped.

In the recordDecisionsGranted when presentWhen absentDifference
Negative nexus opinion45536.0%36.5%−0.5 pts
Unfavorable VA exam59933.9%44.3%−10.4 pts

Why the Board granted or denied restrictive lung disease interstitial pulmonary fibrosis

Most common reasons in grants

  1. Current diagnosis established27
  2. Caused by the service-connected disability8
  3. Criteria for service connection met4
  4. Service connection established2

Most common reasons in denials

  1. No current diagnosis39
  2. VA examiner: less likely than not related to service27
  3. Service records negative or silent26
  4. Preponderance of the evidence against the claim26
  5. No in-service complaints, treatment or diagnosis22
  6. Current diagnosis established14
  7. Criteria for service connection not met8
  8. Evidence weighs against service connection3

Numbers are decisions that gave the reason. Reasons are short phrases extracted by AI from each decision; common wordings of the same reason are grouped. Benefit of the doubt is reported above.

Recent restrictive lung disease interstitial pulmonary fibrosis decisions

Granted

Citation Nr. A26037887J. Kirby · 2026

Competent and credible evidence establishes relation to Hodgkin's disease treated during service.; Veteran's testimony and medical records indicate shortness of breath consistent with radiation therapy.; Presumption of soundness rebutted as Hodgkin's disease diagnosed during service.

Citation Nr. A26035134Michael Lane · 2026

Current diagnosis of interstitial pulmonary fibrosis; In-service exposure to ordnances (explosives, mortars, cement, mercury); Treating VA pulmonologist opinion found potential contribution from ordnances; VA examiner opined less likely than not, but Board gave greater weight to treating physician

Citation Nr. A26031757Michael J. Skaltsounis · 2026

VA examiner noted lung disability resulted from prolonged intubation/tracheostomy, not amputation directly; Examiner's opinion found inadequate as it denied service connection despite acknowledging intermediate factor; Evidence in approximate balance, benefit of doubt applied

Denied

Citation Nr. A26034414John Z. Jones · 2026

Private opinion from chiropractor lacked specialized training; VA examiner found no respiratory insufficiency pathology; VA findings based on objective pulmonary function testing

Citation Nr. A26032152David H. Robertson · 2026

VA pulmonologist opined less likely than not due to service.; VA pulmonologist opined less likely than not due to diabetes.; Agent Orange not a listed risk factor; idiopathic etiology noted.

Citation Nr. A26029546D. Smart · 2026

No treatment in service records; No post-service treatment; VA exam found no diagnosis or findings supporting diagnosis; Veteran's self-diagnosis deemed incompetent; More weight given to medical evidence showing no current diagnosis

Rules that apply to restrictive lung disease interstitial pulmonary fibrosis claims

Research your restrictive lung disease interstitial pulmonary fibrosis case

Narrow by year, judge, evidence or secondary condition, read the decisions, and export a research memo.

Open VA Law Explorer

How these numbers are calculated

  • Rates count decisions in which the Board decided a restrictive lung disease interstitial pulmonary fibrosis issue, by the outcome of that issue. Other issues in the same decision can have different outcomes.
  • “Granted on the merits” leaves out remands and dismissals. “All conditions” is the grant share across every condition issue in the data.
  • The data comes from CaseScribe's AI extraction of public BVA decisions (2017–2026) and can contain errors. It is updated automatically as new decisions are added.